Drugs / Align
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03399903 | May 2017 → Mar 2019 | HIV infectious disease, colitis | AIDS Healthcare Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Align | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03399903 ↗ |
| Route | Oral | “40 participants will be randomized to take Align tablets, once daily for 8 weeks” NCT03399903 ↗ |